Skip to main content

Table 2 SF-36v2 in MD classifications

From: Quality of life in adults with muscular dystrophy

 

DMD

BMD

LGMD

FSHD

CTRL

Physical Function

1.3 ± 3.5 B**,F**,C***

18.4 ± 18.2 C***

6.3 ± 10.3C***

18.2 ± 12.5 C***

95.9 ± 9.3

Role Physical

72.1 ± 26.1 F*,C**

53.8 ± 32.5 C***

59.9 ± 31.5 C***

41.5 ± 26.7 C***

99.2 ± 2.1

Bodily Pain

66.1 ± 16.4C*

58.6 ± 22.2C**

56.1 ± 24.4C**

48.1 ± 28.6C***

87.1 ± 15.8

General Health

55.6 ± 20.1 C**

48.4 ± 19.3 C***

43.3 ± 22.5 C***

44.1 ± 24.2 C***

81.7 ± 11.2

Vitality

63.3 ± 18.0F***

50.0 ± 24.7C*

51.6 ± 17.3

37.9 ± 16.9C***

72.3 ± 19.2

Social Function

84.1 ± 41.9C*

68.8 ± 30.4 C**

76.0 ± 27.4 C*

67.9 ± 29.7 C**

97.7 ± 6.8

Role Emotional

80.6 ± 24.5C*

66.2 ± 32.6 C**

86.8 ± 25.7 F*

69.0 ± 24.1 C**

98.4 ± 4.5

Mental Health

79.0 ± 14.9 F*

74.2 ± 16.0 C*

78.8 ± 14.6

65.0 ± 19.1C**

84.7 ± 8.5

Total Physical Score

34.3 ± 5.4 C***

34.5 ± 6.7 C***

30.2 ± 5.8 C***

30.8 ± 6.3 C***

56.8 ± 3.6

Total Mental Score

58.2 ± 10.5

51.8 ± 9.3

58.3 ± 9.7

49.8 ± 11.0

55.8 ± 3.6

  1. SF36 outcomes. Presented as mean ± SD
  2. DMD Duchenne Muscular Dystrophy, BMD Becker’s Muscular Dystrophy, LGMD Limb-Girdle Muscular Dystrophy, FSHD Facioscapulohumeral Muscular Dystrophy; B denotes significant difference from BMD; LG denotes significant difference from LGMD; F denotes significant difference from FSHD; C denotes significant difference from CTRL; * denotes significance <.05; ** denotes significance <.01; *** denotes significance <.001